Blogs
Healthcare and Medtech Research Reports
Nov 16, 2026
Summary SCLC is the core of the NEC market. Small cell lung cancer makes up roughly 10-15% of lung cancers, with about 250,000 new cases worldwide each year, and most patients are diagnosed at the extensive stage. Extrapulmonary NEC is the biggest unmet need. With an incidence of about 1 per 100,000, it has ...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper